Ask Warren

Sam-A Pharm

009300 · KOSDAQ · ₩009300 · 삼아제약

₩13,670▼ ₩30 (0.22%)End-of-day · Oct 28, 2026 · End-of-day prices.
Trade
Alert me
SellBuy
AnnualQuarterly

Income statement

Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024
Revenue₩19B₩18B₩21B₩15B₩17B₩24B₩20B₩21B
Cost of sales₩8.3B₩7.4B₩9.2B₩6.8B₩7B₩8.5B₩7.5B₩8.8B
Gross profit₩10B₩10B₩12B₩8.4B₩10B₩16B₩12B₩12B
Operating income₩1.9B₩2.1B₩2.7B−₩1.1B₩2B₩7.4B₩3.9B₩1.6B
Net income₩4.4B₩2.2B₩4B−₩54M₩2.7B₩6.3B₩4.3B₩2.1B
Net income to shareholders₩4.4B₩2.2B₩4B−₩54M₩2.7B₩6.3B₩4.3B₩2.1B

Balance sheet

Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024
Total assets₩250B₩248B₩247B₩246B₩249B₩256B₩249B₩245B
Current assets₩132B₩138B₩136B₩127B₩125B₩124B₩113B₩110B
Cash and equivalents₩20B₩15B₩6.6B₩6.3B₩9.4B₩16B₩9.6B₩15B
Total liabilities₩20B₩22B₩19B₩22B₩25B₩35B₩29B₩31B
Current liabilities₩13B₩18B₩14B₩16B₩19B₩28B₩21B₩23B
Borrowings₩2.7B₩1.1B₩2.3B₩3.4B₩4.6B₩5.7B₩6.8B₩4.5B
Total equity₩230B₩226B₩228B₩224B₩224B₩221B₩220B₩214B
Shareholders' equity₩230B₩226B₩228B₩224B₩224B₩221B₩220B₩214B

Cash flow

Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024
Cash from operations₩6.8B₩6.6B₩162M₩720M₩2.2B₩7.6B₩1.1B₩7.3B
Capital spending₩813M₩344M₩633M₩266M₩6.8M₩465M₩1.6B₩1.7B
Free cash flow₩6B₩6.3B−₩470M₩454M₩2.2B₩7.2B−₩577M₩5.5B
Dividends paid₩5.2B₩0₩0₩0₩4.9B₩0₩0₩0

Consolidated where available. Amounts in won.

Also known as: Sam-A Pharm / 삼아제약 / 009300 / KRX:009300

Source: KRX statistical information